company background image
TSOI logo

Therapeutic Solutions International OTCPK:TSOI Stock Report

Last Price

US$0.00025

Market Cap

US$1.3m

7D

-37.5%

1Y

-79.2%

Updated

23 Dec, 2024

Data

Company Financials

Therapeutic Solutions International, Inc.

OTCPK:TSOI Stock Report

Market Cap: US$1.3m

TSOI Stock Overview

Therapeutic Solutions International, Inc. More details

TSOI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Does not have a meaningful market cap ($1M)

Has less than 1 year of cash runway

Makes less than USD$1m in revenue ($85K)

Earnings have declined by 8.2% per year over past 5 years

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Therapeutic Solutions International, Inc. Competitors

Panacea Life Sciences Holdings

OTCPK:PLSH

US$1.3m

China SXT Pharmaceuticals

NasdaqCM:SXTC

US$1.1m

cbdMD

NYSEAM:YCBD

US$2.0m

Avenir Wellness Solutions

OTCPK:AVRW

US$3.0m

Price History & Performance

Summary of share price highs, lows and changes for Therapeutic Solutions International
Historical stock prices
Current Share PriceUS$0.00025
52 Week HighUS$0.0019
52 Week LowUS$0.0002
Beta1.37
1 Month Change-64.29%
3 Month Change-68.75%
1 Year Change-79.17%
3 Year Change-98.80%
5 Year Change-92.86%
Change since IPO-99.83%

Recent News & Updates

Recent updates

Shareholder Returns

TSOIUS PharmaceuticalsUS Market
7D-37.5%-0.3%-2.7%
1Y-79.2%7.9%23.4%

Return vs Industry: TSOI underperformed the US Pharmaceuticals industry which returned 7.9% over the past year.

Return vs Market: TSOI underperformed the US Market which returned 23.4% over the past year.

Price Volatility

Is TSOI's price volatile compared to industry and market?
TSOI volatility
TSOI Average Weekly Movement25.6%
Pharmaceuticals Industry Average Movement10.6%
Market Average Movement6.3%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: TSOI's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: TSOI's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20073Tim Dixonwww.therapeuticsolutionsint.com

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.

Therapeutic Solutions International, Inc. Fundamentals Summary

How do Therapeutic Solutions International's earnings and revenue compare to its market cap?
TSOI fundamental statistics
Market capUS$1.28m
Earnings (TTM)-US$2.41m
Revenue (TTM)US$85.32k

15.0x

P/S Ratio

-0.5x

P/E Ratio

Is TSOI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TSOI income statement (TTM)
RevenueUS$85.32k
Cost of RevenueUS$29.18k
Gross ProfitUS$56.14k
Other ExpensesUS$2.47m
Earnings-US$2.41m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.00047
Gross Margin65.80%
Net Profit Margin-2,824.94%
Debt/Equity Ratio49.0%

How did TSOI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 14:28
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Therapeutic Solutions International, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution